Multicenter phase I/II trial of gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer.
Pressiani T, Balsano R, Giordano L, Milella M, Bergamo F, Bozzarelli S, Noventa S, Ferrrari D, Scartozzi M, Parra HS, Auriemma A, Soldà C, Zaniboni A, Zecchetto C, Rizzato MD, Rimassa L, Santoro A.
Pressiani T, et al. Among authors: parra hs.
Eur J Cancer. 2024 Aug;207:114196. doi: 10.1016/j.ejca.2024.114196. Epub 2024 Jun 29.
Eur J Cancer. 2024.
PMID: 38954899
Clinical Trial.